Tgen presents at 2006 BIO Investor Forum
Wednesday, October 18, at 12:00 p.m. Pacific Time.
H. Stewart Parker, President and Chief Executive Officer, will provide a corporate overview, including an update to the Company's lead product development program for inflammatory arthritis and other corporate activities. The conference is being held at the Palace Hotel, San Francisco, California.
To access the live audio webcast for this conference, please log on to Targeted Genetics' website at www.targetedgenetics.com to register and download any necessary software. The audio presentation and slideshow will be available for replay following the event.
If you're not able to listen to the call, I'll listen
and take notes from the archived file Wednesday night
and post Thursday.
Tgen has something on the order of ~10M cash, and net
tangible assets of about minus $3M I see on yahoo.
That they've kept the lights on all these years is
really something, I don't think you will see TGEN
quotes too much longer--at this valuation it could
just as easily be taken private--any number of Seattle
multimillionaires could own it. And what will probably
happen is Amgen will absorb them. If you don't listen
to the call for clues, I will.
disclaimer--no positon, a couple coworker friends of
mine own it and are down a lot. I probably lost a couple
tens of thousands of dollars on this one a few years ago
and am too timid to own it now. But tgen might be worth
buying if they found an investor down here--sell a big
batch of shares, how about 10M shares at this price to
a local billionaire...it might even be a good investment. |
